XTNT•benzinga•
Xtant Medical Announces Completion Of Secondary Private Sale Of 73.1M Shares By Funds Affiliated With OrbiMed Advisors; Co. Also Says Expects Prelim. Q1 Revenue $32.8M-$33.1M, Representing 18-19% Growth YoY Driven By Orthobiologics And Licensing Revenue
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 16, 2025 by benzinga